Avecho Biotechnology News and Activities
Presence
Headquarters: Australia
Avecho Biotechnology is a company listed under the stock ticker AVE (AU).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Avecho Biotechnology
- Paul Gavin, Chief Executive Officer
- Greg Collier, Chairman of The Board
- Kathy Connell, Non-Executive Director
Popular executive movements at Avecho Biotechnology
- Matt McNamara, Non-Executive Director, has left the company (posted on May 26 2026).
- Naomi Lawrie has joined the company as Company Secretary (posted on May 4 2026).
Create your alert
to follow the executive moves at Avecho Biotechnology.
Pharmaceuticals
Avecho Biotechnology has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Avecho Biotechnology
- Media Coverage | Nine News - Avecho
- Media Centre - Avecho
- First Patient Dosed in Phase III Insomnia Trial - Avecho
- MEDIA | Channel 9 News - Avecho
- Avecho’s Phase III Clinical Trial for Insomnia Commences - Avecho
- Avecho completes meeting with TGA confirming pathway for Phase III Clinical Trial - Avecho
- Ethics Approval for amendments to Phase III Clinical Trial - Avecho
- Podcast: Money News with Scott Haywood - Avecho
- Placement to Advance Phase III Clinical Trial - Avecho
- Avecho reaches two-year stability milestone for its CBD softgel capsule - Avecho
- View more press releases Close
Social media about Avecho Biotechnology
- Avecho Biotechnology on Wikipedia, Google News & Yahoo Finance
- Avecho Biotechnology on LinkedIn, X (Twitter) & YouTube
